Veristat to Assist Cidara with Its Trials for Novel Echinocandin Antifungal CD101
September 15, 2015
Veristat Assists EndoCeutics with NDA Submission for Intravaginal Prasterone
August 24, 2015
Veristat announced that it has been recognized by Inc. Magazine as one of the Countries’ fastest-growing private companies.
July 13, 2015
SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the move of its corporate headquarters to Southborough, Massachusetts. As previously announced, the move was driven by Veristat’s rapid growth in response to the increased demand for full-service clinical research offerings by its pharmaceutical and biotechnology clients.
Veristat Expands Its San Francisco Bay Area Operations: Opens New Office to Support Life Sciences Firms
June 15, 2015
HOLLISTON, MA – June 15, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has opened a new office in San Bruno, California. Located in the heart of the San Francisco Bay Area life sciences community, the office will house Veristat’s West Coast operations, and will provide a full range of clinical services to clients developing therapies in all areas of biotechnology, pharmaceuticals, diagnostics and medical devices.
June 2, 2015
Veristat will Move Corporate Headquarters to Southborough, MA This Summer
National Association of Professional Women Announces Cynthia Henderson, Executive Vice President of Operations at Veristat, LLC, a 2015 Professional Woman of the Year
March 17, 2015
Garden City, NY (PRWEB) March 17, 2015
February 6, 2015
Veristat and Molecular Templates Inc. enter into Preferred Provider Agreement for Refractory non-Hodgkin’s B-Cell Lymphoma trial
October 10, 2014
For Immediate Release